Authors:
Blann, AD
Gurney, D
Wadley, M
Bareford, D
Stonelake, P
Lip, GYH
Citation: Ad. Blann et al., Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and vonWillebrand factor, BL COAG FIB, 12(1), 2001, pp. 43-50
Citation: If. Islim et al., A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension, PLATELETS, 12(5), 2001, pp. 274-278
Authors:
Belgore, FM
Lip, GYH
Bareford, D
Wadley, M
Stonelake, P
Blann, AD
Citation: Fm. Belgore et al., Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: A comparison with breast cancer, AM J HEMAT, 66(1), 2001, pp. 59-61
Authors:
Marwah, SS
Wheelwright, D
Blann, AD
Rea, C
Beresford, R
Phillips, JD
Wright, J
Bareford, D
Citation: Ss. Marwah et al., Vitamin E correlates inversely with non-transferrin-bound iron in sickle cell disease, BR J HAEM, 114(4), 2001, pp. 917-919
Authors:
Matutes, E
Taylor, GP
Cavenagh, J
Pagliuca, A
Bareford, D
Domingo, A
Hamblin, R
Kelsey, S
Mir, N
Reilly, JT
Citation: E. Matutes et al., Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients, BR J HAEM, 113(3), 2001, pp. 779-784
Authors:
Blann, A
Hewitt, J
Siddiqui, F
Bareford, D
Citation: A. Blann et al., Racial background is a determinant of average warfarin dose required to maintain the INR between 2 center dot 0 and 3 center dot 0, BR J HAEM, 107(1), 1999, pp. 207-209
Authors:
Pearson, TC
Bareford, D
Craig, J
Egan, EL
Green, AR
Lucas, GS
Ludlam, CA
McMullin, MF
Messinezy, M
Oscier, DG
Reilly, JT
Citation: Tc. Pearson et al., The management of 'low-risk' and 'intermediate-risk' patients with primarythrombocythaemia, BR J HAEM, 106(3), 1999, pp. 833-834